AKTX 0.77 ▼ -6.09% Live Trading Data - Stocknear

Akari Therapeutics

NASDAQ: AKTX · Real-Time Price · USD
0.77
-0.05 (-6.09%)
At close: Oct 16, 2025, 3:59 PM
0.80
4.05%
After-hours: Oct 16, 2025, 05:33 PM EDT
-6.09%
Bid 0.77
Market Cap 12.56K
Revenue (ttm) 26K
Net Income (ttm) -12.27M
EPS (ttm) -2.58
PE Ratio (ttm) -0.3
Forward PE -2.13
Analyst Buy
Dividends n/a
Ask 0.83
Volume 122,624
Avg. Volume (20D) 197,034
Open 0.81
Previous Close 0.82
Day's Range 0.77 - 0.84
52-Week Range 0.57 - 3.15
Beta 0.36
Ex-Dividend Date n/a

About AKTX

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol AKTX
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for AKTX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
1 day ago
-16.34%
Akari Therapeutics shares are trading lower after ... Unlock content with Pro Subscription
4 weeks ago
+5.11%
AKTX stock has given up its prior loss. Akari Therapeutics shares were trading lower. The company announced that it has filed a provisional patent application with the United States Patent and Trademark Office covering the its antibody drug conjugate platform using its spliceosome payload PH1 for treating cancer by modulating alternative splicing within cancer cells.